Long-Term Fate of the Hepatocyte Hyperplastic Foci Induced by a Two Stage Carcinogenetic Protocol

  • Gino Malvaldi
  • Elisabetta Chieli
  • Adonella Marradi
  • Michela Saviozzi


The appearance of a liver hepatocellular neoplasm is always preceded by the development of histochemically detectable hepatocyte focal lesions (HFL) which are believed to be related to the development of hepatoma (for recent reviews: Bannasch1, Moore and Kitagawa2, Farber and Sarma3). A large discrepancy, however, usually exists between the number of HFL and the number of tumors per liver. Since initiation is thought as an irreversible step in the natural history of neoplasia and HFL are considered a cell population derived from initiated hepatocytes4, HFL as such should be stable in time, i.e. they should not disappear after withdrawal of the inducing carcinogen(s). This has been actually observed in some models of liver carcinogenesis5–7. In others, however, many of the HFL present at the end of the carcinogen administration cycle seem to disappear with time8–10.


Mitotic Index Apoptotic Index Phenotypic Complexity Hyperplastic Nodule Liver Carcinogenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. Bannasch, Preneoplastic lesions as end points in carcinogenicity testing, l, Hepatic preneoplasia, Carcinogenesis 7:698 (1986).Google Scholar
  2. 2.
    M. A. Moore and T. Kitagawa, Hepatocarcinogenesis in the rat: The effect of promoters and carcinogens in vivo and in vitro, Int. Rev. Cytol. 101:125 (1986).PubMedCrossRefGoogle Scholar
  3. 3.
    E. Farber and D. S. R. Sarma, Biology of disease, Hepatocarcinogenesis: a dynamic cellular perspective, Lab. Invest. 56:A (1987).Google Scholar
  4. 4.
    D. B. Solt, E. Cayama, D. S. R. Sarma and E. Farber, Persistence of resistant putative preneoplastic hepatocytes induced by N-Nitrosodiethylamine or N-methyl-N-nitrosourea, Cancer Res. 40:1112 (1980).PubMedGoogle Scholar
  5. 5.
    E. Scherer, M. Hoffmann, P. Emmelot and M. Friedrich-Freksa, Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethylnitrosamine and partial hepatectomy, J. Natl. Cancer Inst. 49:93 (1972).PubMedGoogle Scholar
  6. 6.
    A. M. Moore, D. Mayer and P. Bannasch, The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine, Carcinogenesis 3:1429 (1982).PubMedCrossRefGoogle Scholar
  7. 7.
    T. Goldsworthy, M. A. Campbell and M. C. Pitot, The natural history and dose response characteristics of enzyme altered foci in rat liver following phenobarbital and diethylnitrosamine administration, Carcinogenesis 5:67 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    G. M. Williams and K. Watanabe, Quantitative kinetics of development of N-2 fluorenylecetamide-induced altered hyperplastic hepatocellular foci resistant to iron accumulation and of the reversion or persistence following removal of carcinogen, J. Natl. Cancer Inst. 61:113 (1978).PubMedGoogle Scholar
  9. 9.
    M. Tatematsu, Y. Nagamine and E. Farber, Redifferentiation as a basis for remodeling of carcinogen induced hepatocytes nodules to normal appearing liver, Cancer Res. 43:5049 (1983).PubMedGoogle Scholar
  10. 10.
    K. Enomoto and E. Farber, Kinetics of phenotypic maturation or remodeling of hyperplastic nodules during liver carcinogenesis, Cancer Res. 42:2330 (1982).PubMedGoogle Scholar
  11. 11.
    G. Malvaldi, E. Chieli and M. Saviozzi, Promotive effects of thiobenzamide on liver carcinogenesis, Gann 74:469 (1983).PubMedGoogle Scholar
  12. 12.
    G. Malvaldi, E. Chieli and M. Saviozzi, Characterization of the promoting activity of Thiobenzamide on liver carcinogenesis, Toxicol. Pathol. 14:370 (1986).PubMedCrossRefGoogle Scholar
  13. 13.
    N. Hirota and G. M. Williams, The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis, Anu. J. Pathol. 95:317 (1979).Google Scholar
  14. 14.
    A. M. Rutenburg, M. Kim, J. W. Fischbein, J. S. Hanker, H. L. Wasserkrug and A. M. Seligman, Histochemical and ultrastructural demonstration of gamma glutamyltranspeptidase activity, J. Histochem. Cytochem. 17:517 (1969).PubMedCrossRefGoogle Scholar
  15. 15.
    M. A. Campbell, H. C. Pitot, V. R. Potter and B. A. Laishes, Application of quantitative stereology to the evaluation of enzyme altered foci in rat liver, Cancer Res. 41:465 (1982).Google Scholar
  16. 16.
    T. D. V. Swinscow, “Statistics at square one”, British Medical Association, London (1978).Google Scholar
  17. 17.
    M. A. Moore, M. J. Hacker and P. Bannasch, Phenotypic instability in focal and nodular lesions induced in a short-term system in the rat liver, Carcinogenesis 4:595 (1983).PubMedCrossRefGoogle Scholar
  18. 18.
    M. Tatematsu, T. Takano, R. Hasegawa, K. Imaida, J. Nakanowatari and N. Ito, A sequential quantitative study of the reversibility or irreversibility of liver hyperplastic nodules in rats exposed to hepatocarcinogens, Gann 71:483 (1980).Google Scholar
  19. 19.
    A. Columbano, G. M. Ledda-Columbano, P. M. Rao, S. Rajalakshmi and D. S. R. Sarma, Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells, Am. J. Pathol. 116:441 (1984).PubMedGoogle Scholar
  20. 20.
    W. Bursch, B. Lauer, I. Timmermann-Troisiener, G. Barthel, J. Schuppler and R. Schulte-Hermann, Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters, Carcinogenesis 5:453 (1984).PubMedCrossRefGoogle Scholar
  21. 21.
    A. H. Wyllie, J. F. R. Kerr and A. R. Currie, Cell death: the significance of apoptosis, Int. Rev. Cytol. 68:251 (1980).PubMedCrossRefGoogle Scholar
  22. 22.
    R. G. Cameron, K. Imaida, H. Tsuda and H. Ito, Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine, Cancer Res. 42:2426 (1982).PubMedGoogle Scholar
  23. 23.
    C. Peraino, E. F. Staffeldt, B. A. Carnes, V. A. Ludeman, J. A. Blomquist and S. V. Vesselinovitch, Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or Benzo(a)-pyrene withine one day after birth, Cancer Res. 44:3340 (1984).PubMedGoogle Scholar
  24. 24.
    T. L. Goldsworthy and H. C. Pitot, The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital, Carcinogenesis 6:1261 (1985).PubMedCrossRefGoogle Scholar
  25. 25.
    M. D. Estadella, M. J. Pujol and J. Domingo, Enzyme pattern and growth rate of liver preneoplastic clones during carcinogenesis by diethylnitrosamine, Oncology 41:276 (1984).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Gino Malvaldi
    • 1
  • Elisabetta Chieli
    • 1
  • Adonella Marradi
    • 1
  • Michela Saviozzi
    • 1
  1. 1.Istituto di Patologia Generale Scuola MedicaUniversità di PisaPisaItaly

Personalised recommendations